# LCI Apheresis to Obtain Plasma or White Blood Cells

> **NCT00562601** · — · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 864 (actual)

## Conditions studied

- Apheresis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00562601
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 1988-03-28
- **Primary completion:** 2020-01-14
- **Final completion:** 2020-01-14
- **Target enrollment:** 864 (ACTUAL)
- **Why stopped:** Closed by the Sponsor/DSMB/IRB
- **Last updated:** 2020-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00562601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00562601, "LCI Apheresis to Obtain Plasma or White Blood Cells". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00562601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*